Nautilus Biotechnology In...
(NAUT)
undefined
undefined%
At close: undefined
2.00
2.05%
After-hours Dec 13, 2024, 04:26 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -63.67M | -57.92M | -50.31M | -15.62M | -9.62M | 626.60M |
| Depreciation & Amortization | 5.71M | 3.42M | 2.84M | 2.35M | 548.00K | - |
| Stock-Based Compensation | 12.14M | 10.38M | 7.93M | 369.00K | 110.00K | - |
| Other Working Capital | -3.61M | -227.00K | -1.28M | -1.51M | -545.00K | - |
| Other Non-Cash Items | -2.66M | -890.00K | 320.00K | 295.00K | -157.00K | -866.23M |
| Deferred Income Tax | - | - | - | - | 774.50K | - |
| Change in Working Capital | -3.22M | -788.00K | -22.00K | -1.39M | -545.00K | 1.33M |
| Operating Cash Flow | -51.71M | -45.81M | -39.24M | -14.00M | -9.66M | -238.30M |
| Capital Expenditures | -2.44M | -2.32M | -2.27M | -921.00K | -926.00K | - |
| Acquisitions | - | -163.18M | 136.69K | 24.36K | - | - |
| Purchase of Investments | -112.89M | -186.59M | -221.79M | -68.36M | - | - |
| Sales Maturities Of Investments | 71.60M | 163.18M | 85.10M | 44.00M | - | - |
| Other Investing Acitivies | - | 163.18M | -136.69K | -24.36K | 4.98M | 1.20M |
| Investing Cash Flow | -43.73M | -25.74M | -138.96M | -25.28M | 4.05M | 1.20M |
| Debt Repayment | - | - | - | - | - | - |
| Common Stock Repurchased | 264.00K | 232.00K | - | - | -874.33K | -1.20M |
| Dividend Paid | - | - | - | - | - | - |
| Other Financial Acitivies | 368.00K | 562.00K | 327.45M | 75.90M | 36.00K | 145.19B |
| Financial Cash Flow | 368.00K | 562.00K | 327.45M | 75.90M | 36.00K | 145.19B |
| Net Cash Flow | -95.08M | -70.98M | 149.24M | 36.62M | -1.20B | 1.20M |
| Free Cash Flow | -54.15M | -48.13M | -41.51M | -14.92M | -10.59M | -238.30M |